Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1

Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1

US Patent 7622256 · Granted Nov 24, 2009

Estimated economic value: $657,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Telomerase reverse transcriptase (TERT) expression enhancing compounds and metho2025
Extended local release of anti-CSFR1 antibodies2025
Antibodies that bind interleukin-2 and uses thereof2025
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (2024
Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof2023
Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cel2023
8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (2023
Extended local release of anti-CSFR1 antibodies2022
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2022
Arginase inhibitor combination therapies2022
Combination therapy with glutaminase inhibitors and immuno-oncology agents2021